UPDATED Jan 03, 2026
Discover U.S. Pharmaceuticals & Biotech Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ANL | US$1.38 | -15.9% | -40.0% | US$50.9m | n/a | PB6.4x | n/a | n/a | ||
KTTA | US$1.19 | 6.3% | -61.9% | US$26.7m | US$3.00 | PB2.2x | n/a | n/a | ||
SPRC | US$1.40 | -4.8% | -87.4% | US$4.6m | n/a | PS3.5x | n/a | n/a | ||
CYPH | US$1.13 | -5.8% | -66.3% | US$64.0m | n/a | PB23.8x | n/a | n/a | ||
MENS | US$3.41 | 5.9% | n/a | US$262.2m | n/a | PE-86.9x | n/a | n/a | ||
NBY | US$5.87 | 21.0% | 850.5% | US$739.7m | n/a | PS71.8x | n/a | 13.6% | ||
SCNI | US$0.73 | 3.7% | -79.7% | US$2.3m | n/a | PE6.7x | n/a | n/a | ||
CELU | US$1.21 | -9.7% | -47.4% | US$34.3m | n/a | PE-0.4x | n/a | n/a | ||
LIMN | US$0.64 | -1.0% | -94.3% | US$17.3m | n/a | PE-7.6x | n/a | n/a | ||
ATON | US$0.77 | 16.6% | -84.6% | US$5.8m | n/a | PE-0.9x | n/a | n/a | ||
ARMP | US$6.56 | -0.3% | 233.0% | US$238.8m | US$9.00 | PS47.3x | n/a | n/a | ||
XBIT | US$2.38 | -3.6% | -46.2% | US$72.6m | n/a | PB0.4x | n/a | n/a | ||
MIRA | US$1.49 | -1.3% | 18.3% | US$62.4m | US$17.75 | PB8.3x | n/a | n/a | ||
QCLS | US$4.23 | -11.1% | -96.4% | US$17.6m | n/a | PB1.2x | n/a | n/a | ||
TXMD | US$1.65 | -5.2% | 12.2% | US$19.1m | n/a | PE261.6x | n/a | n/a | ||
BIAF | US$1.22 | 4.3% | -95.7% | US$5.5m | n/a | PB0.6x | n/a | n/a | ||
CPIX | US$3.98 | -3.4% | 73.0% | US$59.5m | n/a | PS1.4x | n/a | n/a | ||
CURX | US$0.37 | 1.4% | n/a | US$10.4m | n/a | PB0.7x | n/a | n/a | ||
AIXC | US$2.40 | -4.8% | -47.1% | US$16.9m | n/a | PB6.9x | n/a | n/a | ||
RDHL | US$1.03 | -9.6% | -84.2% | US$3.4m | n/a | PE-0.4x | n/a | n/a | ||
IBIO | US$2.02 | 6.9% | -17.6% | US$45.4m | US$4.77 | PS90.8x | S-15.0% | n/a | ||
RGC | US$20.54 | -2.9% | 14,997.2% | US$10.2b | n/a | PB2089.8x | n/a | n/a | ||
NCNA | US$3.64 | 10.0% | -98.6% | US$15.1m | n/a | PB0.4x | n/a | n/a | ||
CTNM | US$11.39 | -8.2% | -21.6% | US$332.4m | US$21.83 | PB1.8x | S42.8% | n/a |